Gladstone NOW: The Campaign Join Us on the Journey ✕
1 - 8 of 8 Results Clear All
A daily pill to prevent HIV has reduced infections nationwide, and researchers hope that a long-acting injectable form will help expand protection.
HIV/AIDS Grant Lab
Thanks to the successful implementation of HIV treatment and prevention programs, we have never been closer to achieving our goal of ending new HIV infections.
HIV/AIDS Grant Lab
For more than three decades, the AIDS pandemic has swept the world. Different groups have been dealing with this tragedy in a variety ways. Gladstone has one of the premier HIV research teams, but others have focused their efforts on outreach, treatment, and prevention.
Grant Lab HIV/AIDS
A new paper reported no link between taking Truvada for oral PrEP and experiencing depression.
HIV/AIDS Virology Grant Lab
Pre-exposure prophylaxis, or PrEP, may be the key to helping San Francisco become the first city to stop HIV.
HIV/AIDS Grant Lab
SAN FRANCISCO, CA—In 2012 the HIV antiretroviral drug Truvada became the first and only medication approved by the FDA for HIV prevention.
Grant Lab Virology HIV/AIDS
SAN FRANCISCO, CA—New research from an international team of HIV/AIDS experts has reaffirmed the effectiveness of Truvada—the first and only medication approved by the FDA for HIV prevention.
Grant Lab HIV/AIDS
San Francisco, CA—In a finding with the potential to fundamentally change strategies to slow the global HIV epidemic, a new study called iPrEx shows that individuals at high risk for HIV infection who took a single daily tablet containing two widely used HIV medications, emtricitabine and tenofov
Grant Lab HIV/AIDS
